SummitTX Capital »

Nurix Therapeutics shares owned by SummitTX Capital

Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by SummitTX Capital from 13F filings

Historical chart of SummitTX Capital investment in Nurix Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nurix Therapeutics held by SummitTX Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nurix Therapeutics by SummitTX Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $497k 21k 24.26

More positions owned by SummitTX Capital

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Analog Devices (ADI)
MKS Instruments (MKSI)
Asml Hldg Nv N Y Registry Shs (ASML)
Warner Bros Discovery Com Ser A (WBD)
Applied Materials (AMAT)
Select Sector Spdr Tr St Str Indl Etf (XLI)
Nxp Semiconductors N V (NXPI)
Amazon (AMZN)
O'reilly Automotive (ORLY)
Cbre Group Cl A (CBRE)
Electronic Arts (EA)
Micron Technology (MU)
3M Company (MMM)

View all positions for SummitTX Capital

Top funds holding Nurix Therapeutics

BlackRock
Vestal Point Capital
Deep Track Capital
Rubric Capital Management
FMR
State Street Corporation
Morgan Stanley
Baker Bros. Advisors
Vanguard Capital Management
Perceptive Advisors
Redmile Group
T. Rowe Price Associates
General Atlantic
Geode Capital Management
Pictet Asset Management Holding SA

View all funds holding Nurix Therapeutics